Cargando…
DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities
Antitumor therapeutic strategies that fundamentally rely on the induction of DNA damage to eradicate and inhibit the growth of cancer cells are integral approaches to cancer therapy. Although DNA-damaging therapies advance the battle with cancer, resistance, and recurrence following treatment are co...
Autores principales: | Abuetabh, Yasser, Wu, H. Helena, Chai, Chengsen, Al Yousef, Habib, Persad, Sujata, Sergi, Consolato M., Leng, Roger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636249/ https://www.ncbi.nlm.nih.gov/pubmed/36207426 http://dx.doi.org/10.1038/s12276-022-00863-4 |
Ejemplares similares
-
The SWIB/MDM2 motif of UBE4B activates the p53 pathway
por: Wu, H. Helena, et al.
Publicado: (2023) -
Graphene Oxide Nanoparticles Induce Apoptosis in wild-type and CRISPR/Cas9-IGF/IGFBP3 knocked-out Osteosarcoma Cells
por: Burnett, Mervin, et al.
Publicado: (2020) -
Osteosarcoma progression is associated with increased nuclear levels and transcriptional activity of activated β-Catenin
por: Ali, Noureen, et al.
Publicado: (2019) -
Canine Liver Transplantation Model and the Intermediate Filaments of the Cytoskeleton of the Hepatocytes
por: Sergi, Consolato, et al.
Publicado: (2012) -
The Regulation of Tumor Suppressor p63 by the Ubiquitin-Proteasome System
por: Armstrong, Stephen R., et al.
Publicado: (2016)